Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.32 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.32 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1032543 | 0.76 | LMNA (0.40) | LMNASLC1A3SLC1A2SLC1A1TP53 | |
| SCHEMBL11281608 | 0.72 | LMNA (0.53) | LMNASLC1A3SLC1A2SLC1A1TP53 | |
| SCHEMBL14422655 | 0.72 | LMNA (0.53) | LMNASLC1A3SLC1A2SLC1A1TP53 | |
| SCHEMBL312981 | 0.72 | LMNA (0.53) | LMNASLC1A3SLC1A2SLC1A1TP53 | |
| SCHEMBL11283030 | 0.71 | LMNA (0.46) | LMNASLC1A3SLC1A2SLC1A1TP53 | |
| SCHEMBL8358990 | 0.70 | TP53 (0.41) | LMNASLC1A3SLC1A2SLC1A1TP53 | |
| SCHEMBL466763 | 0.70 | LMNA (0.37) | LMNASLC1A3SLC1A2SLC1A1TP53 | |
| SCHEMBL8664773 | 0.70 | LMNA (0.50) | LMNASLC1A3SLC1A2SLC1A1TP53 | |
| SCHEMBL11381677 | 0.69 | CYP3A4 (0.33) | LMNASLC1A3SLC1A2SLC1A1CYP3A4 | |
| SCHEMBL15911845 | 0.69 | LMNA (0.48) | LMNATP53CYP3A4ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2851386-B1 | RESIN COMPOSITION FOR OPTICAL STEREOLITHOGRAPHY | CMET INC (JP) | 2017-08-16 | — | — | EP | disclosed |
| EP-2851386-A1 | RESIN COMPOSITION FOR OPTICAL STEREOLITHOGRAPHY | Cmet Inc. (JP) | 2015-03-25 | — | — | EP | disclosed |
| EP-1752463-B1 | NOVEL FLUORINATED ALKYLFLUOROPHOSPHORIC ACID SALT OF ONIUM AND TRANSITION METAL COMPLEX | SAN APRO LTD (JP) | 2013-07-17 | — | — | EP | disclosed |
| US-8383862-B2 | Salt compound, cationic polymerization initiator and cationically polymerizable composition | ADEKA CORPORATION (JP) | 2013-02-26 | — | — | US | disclosed |
| EP-2223948-B1 | SALT COMPOUND, CATIONIC POLYMERIZATION INITIATOR AND CATIONICALLY POLYMERIZABLE COMPOSITION | ADEKA CORP (JP) | 2013-01-23 | — | — | EP | disclosed |
| US-20100267857-A1 | SALT COMPOUND, CATIONIC POLYMERIZATION INITIATOR AND CATIONICALLY POLYMERIZABLE COMPOSITION | ADEKA CORPORATION (JP) | 2010-10-21 | — | — | US | disclosed |
| EP-2223948-A1 | SALT COMPOUND, CATIONIC POLYMERIZATION INITIATOR AND CATIONICALLY POLYMERIZABLE COMPOSITION | Adeka Corporation (JP) | 2010-09-01 | — | — | EP | disclosed |
| US-7709598-B2 | Fluorinated alkyl fluorophoshoric acid salts of onium and transition metal complex | SAN-APRO LIMITED (JP) | 2010-05-04 | — | — | US | disclosed |
| US-20070225458-A1 | Novel Fluorinated Alkyl Fluorophosphoric Acid Salts of Onium and Ttransition Metal Complex | SAN-APRO LIMITED (JP) | 2007-09-27 | — | — | US | disclosed |
| EP-1752463-A1 | NOVEL FLUORINATED ALKYLFLUOROPHOSPHORIC ACID SALT OF ONIUM AND TRANSITION METAL COMPLEX | San-Apro Limited (JP) | 2007-02-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267857-A1 | SALT COMPOUND, CATIONIC POLYMERIZATION INITIATOR AND CATIONICALLY POLYMERIZABLE COMPOSITION | RFC5, RER1, ARF5 | LMNA 4321/4885SLC1A3 1115/4885SLC1A2 2185/4885 |
| US-20070225458-A1 | Novel Fluorinated Alkyl Fluorophosphoric Acid Salts of Onium and Ttransition Metal Complex | AS3MT, TTR, PFAS | LMNA 829/4885SLC1A3 1420/4885SLC1A2 1417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.